HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibody responses induced by recombinant ALV-A gp85 protein vaccine combining with CpG-ODN adjuvant in breeder hens and the protection for their offspring against early infection.

Abstract
To observe the antibody responses induced by recombinant A subgroup avian leukosis virus (ALV-A) gp85 protein vaccine plus CpG-ODN adjuvant and the protection of maternal antibodies (MAbs) for the hatched chickens against early infection, the gp85 gene was amplified from the proviral cDNA of ALV-A-SDAU09C1 strain using PCR and the recombinant plasmid containing target gene was constructed and expressed in EscherichiaColi. The expressed product was confirmed using SDS-PAGE and western blot that it is about 46KD of recombinant protein. The purified recombinant proteins combining with CpG-ODN adjuvant or Freund's adjuvant were inoculated into the breeder hens, the ALV-A antibodies in serum and in egg-yolk were detected; the fertilized eggs from the vaccinated hens with different titers of egg-yolk antibody were hatched and then challenged with 10(4.2)/0.1mL TCID50 of ALV-A-SDAU09C1 strain, all the hatched chickens were weekly detected for the viremias and the cloacal swab P27 antigen and pathological lesions; the neutralizing test of antisera in vitro was conducted. The results showed that the recombinant gp85 proteins combining with CpG-ODN adjuvant could induce the breeder hens to produce better antibody responses than gp85 protein with Freund's adjuvant or without adjuvant; the MAbs with higher titers induced by CpG-ODN+gp85 proteins could obviously decrease the ratios of viremias (13% vs 33%), cloacal detoxification (20% vs 67%) and death (0% vs 22%) caused by ALV-A infection than those by gp85 protein without adjuvant. The results of the neutralizing test indicated that the antisera from the hatched chickens could neutralize the ALV-A-SDAU09C1 strain in vitro, but which depends on the antibody titers. The results of IFA confirmed that the serum antibody could combine with the ALV in DF1 cells. It can be concluded that the prepared ALV-A gp85 subunit vaccine combining with CpG-ODN adjuvant could induce the breeder hens to produce better neutralizing antibody responses and protect 80% of their offspring chickens against early infection.
AuthorsDandan Zhang, Hongmei Li, Zhongsheng Zhang, Shuhong Sun, Ziqiang Cheng, Jianzhu Liu, Peng Zhao, Qingya Ren, Huijun Guo
JournalAntiviral research (Antiviral Res) Vol. 116 Pg. 20-6 (Apr 2015) ISSN: 1872-9096 [Electronic] Netherlands
PMID25637708 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier B.V. All rights reserved.
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • CPG-oligonucleotide
  • Oligodeoxyribonucleotides
  • Recombinant Proteins
  • Vaccines, Subunit
  • Viral Vaccines
  • Freund's Adjuvant
Topics
  • Adjuvants, Immunologic
  • Animals
  • Antibodies, Neutralizing (analysis, blood, immunology)
  • Antibodies, Viral (blood, immunology)
  • Avian Leukosis (prevention & control)
  • Avian Leukosis Virus (genetics, immunology)
  • Chickens
  • Cloaca (virology)
  • Egg Yolk (immunology, virology)
  • Escherichia coli (genetics)
  • Freund's Adjuvant (administration & dosage)
  • Oligodeoxyribonucleotides (administration & dosage, immunology)
  • Poultry Diseases (prevention & control, virology)
  • Recombinant Proteins (immunology)
  • Vaccines, Subunit (administration & dosage, immunology)
  • Viral Vaccines (administration & dosage, immunology)
  • Viremia (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: